Jiping Zha
177 works · 13,174 citations · h-index 35
Top works
- Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL
- Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death
- BH3 Domain of BAD Is Required for Heterodimerization with BCL-XL and Pro-apoptotic Activity
- Posttranslational N-Myristoylation of BID as a Molecular Switch for Targeting Mitochondria and Apoptosis
- Somatic Mutations Lead to an Oncogenic Deletion of Met in Lung Cancer
- Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells
- Oncogenic BRAF Is Required for Tumor Growth and Maintenance in Melanoma Models
- Therapeutic antibody targeting of individual Notch receptors
- Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
- Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors
- Bad -deficient mice develop diffuse large B cell lymphoma
- Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research
- The Mitochondrial Inner Membrane Protein Mitofilin Controls Cristae Morphology
- Final efficacy results from OAM4558g, a randomized phase II study evaluating MetMAb or placebo in combination with erlotinib in advanced NSCLC.
- MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
- Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis
- Durable Complete Response of Metastatic Gastric Cancer with Anti-Met Therapy Followed by Resistance at Recurrence
- Uniform nomenclature for the mitochondrial contact site and cristae organizing system
- Biomarker Analyses from a Placebo-Controlled Phase II Study Evaluating Erlotinib ± Onartuzumab in Advanced Non–Small Cell Lung Cancer: MET Expression Levels Are Predictive of Patient Benefit
- Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer